MX2017004175A - Dispositivo de inhalacion. - Google Patents

Dispositivo de inhalacion.

Info

Publication number
MX2017004175A
MX2017004175A MX2017004175A MX2017004175A MX2017004175A MX 2017004175 A MX2017004175 A MX 2017004175A MX 2017004175 A MX2017004175 A MX 2017004175A MX 2017004175 A MX2017004175 A MX 2017004175A MX 2017004175 A MX2017004175 A MX 2017004175A
Authority
MX
Mexico
Prior art keywords
inhalation device
pulmonary administration
sulfomethylated polymyxin
patient
aqueous solution
Prior art date
Application number
MX2017004175A
Other languages
English (en)
Inventor
Bencic Nenad
Original Assignee
Xellia Pharmaceuticals Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xellia Pharmaceuticals Aps filed Critical Xellia Pharmaceuticals Aps
Publication of MX2017004175A publication Critical patent/MX2017004175A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/003—Particle size control by passing the aerosol trough sieves or filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Se describe en la presente un dispositivo de administracion pulmonar, el cual comprende una unidad de boquilla de nebulizacion y un cartucho que contiene una solucion acuosa que comprende desde 70 hasta 400 mg A/ml de una polimixina sulfometilada, y el uso de polimixina sulfometilada en un dispositivo para administracion pulmonar en un paciente que lo requiere.
MX2017004175A 2014-10-03 2015-10-01 Dispositivo de inhalacion. MX2017004175A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462059748P 2014-10-03 2014-10-03
PCT/EP2015/072736 WO2016050933A1 (en) 2014-10-03 2015-10-01 Inhalation device

Publications (1)

Publication Number Publication Date
MX2017004175A true MX2017004175A (es) 2017-08-28

Family

ID=54249495

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017004175A MX2017004175A (es) 2014-10-03 2015-10-01 Dispositivo de inhalacion.

Country Status (26)

Country Link
US (1) US11033602B2 (es)
EP (2) EP3520777B1 (es)
JP (1) JP6626890B2 (es)
KR (1) KR102494511B1 (es)
CN (1) CN106999542B (es)
AU (1) AU2015326847B2 (es)
BR (1) BR112017006816A2 (es)
CA (1) CA2962120C (es)
CO (1) CO2017004442A2 (es)
CY (1) CY1121803T1 (es)
DK (1) DK3200762T3 (es)
ES (1) ES2721401T3 (es)
HR (1) HRP20190747T1 (es)
HU (1) HUE044289T2 (es)
IL (1) IL251480B (es)
LT (1) LT3200762T (es)
MX (1) MX2017004175A (es)
PH (1) PH12017500538A1 (es)
PL (1) PL3200762T3 (es)
PT (1) PT3200762T (es)
RS (1) RS58792B1 (es)
RU (1) RU2702335C2 (es)
SG (1) SG11201702666SA (es)
SI (1) SI3200762T1 (es)
TR (1) TR201906108T4 (es)
WO (1) WO2016050933A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6633061B2 (ja) 2014-10-03 2020-01-22 クセリア ファーマシューティカルズ エーピーエスＸｅｌｌｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡｐＳ 組成物
CN112546030A (zh) * 2019-09-26 2021-03-26 盈科瑞（天津）创新医药研究有限公司 一种吸入用多粘菌素e甲磺酸钠溶液及其制备方法
US20230052317A1 (en) * 2021-08-05 2023-02-16 Zambon S.P.A. Treatment of non-cystic fibrosis bronchiectasis

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062895A (en) 1962-12-13 1967-03-22 Wellcome Found Sulphomethyl derivatives of polymxin
DE1906699A1 (de) 1968-02-12 1970-02-05 Pfizer Neue Polymyxinderivate und Verfahren zu deren Herstellung
FR1586834A (es) 1968-02-12 1970-03-06
WO1989009626A1 (en) 1988-04-07 1989-10-19 Luther Ronald B Non-thrombogenic intravascular time release catheter
SE9201246D0 (sv) 1992-04-21 1992-04-21 Kabi Pharmacia Ab Injection cartridge arrangement
NL9401260A (nl) 1993-11-12 1995-06-01 Cornelis Johannes Maria Van Ri Membraan voor microfiltratie, ultrafiltratie, gasscheiding en katalyse, werkwijze ter vervaardiging van een dergelijk membraan, mal ter vervaardiging van een dergelijk membraan, alsmede diverse scheidingssystemen omvattende een dergelijk membraan.
WO1998020836A2 (en) * 1996-11-15 1998-05-22 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
US5767068A (en) * 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
CA2447600C (en) 2001-05-18 2015-10-20 Chiron Corporation Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
US20040022740A1 (en) 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
EP1340506B1 (en) 2002-03-01 2006-12-27 CHIESI FARMACEUTICI S.p.A. Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US8329645B2 (en) * 2008-02-08 2012-12-11 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
DE102008030267B3 (de) 2008-06-19 2010-01-28 Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg Verfahren zum Befüllen von Doppelkammersystemen in vorsterilisierbaren Trägersystemen und vorsterilisierbares Trägersystem
JP5430769B2 (ja) 2009-10-08 2014-03-05 エス・ホー・エル・グループ・アクチボラゲット 計量液滴吸入器
EP2470555B1 (en) 2009-10-30 2014-12-24 Xellia Pharmaceuticals ApS Method for purification of colistin and purified colistin components
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
CN102531955B (zh) 2011-09-16 2014-02-19 浙江众益制药股份有限公司 奥沙拉秦钠的制备方法和甲磺化反应的后处理方法
SI2943503T1 (sl) 2013-01-11 2017-11-30 Xellia Pharmaceuticals Aps Polimiksini, sestava, postopki priprave in postopki uporabe
TW201522364A (zh) 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉（ｃｍｓ）之定性方法
KR20170032348A (ko) 2014-07-09 2017-03-22 셀리아 파마슈티칼즈 에이피에스 저 치환된 폴리믹신 및 이의 조성물
JP6633061B2 (ja) * 2014-10-03 2020-01-22 クセリア ファーマシューティカルズ エーピーエスＸｅｌｌｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡｐＳ 組成物

Also Published As

Publication number Publication date
CA2962120C (en) 2023-09-19
AU2015326847B2 (en) 2018-11-29
IL251480B (en) 2019-09-26
SI3200762T1 (sl) 2019-08-30
KR20170062521A (ko) 2017-06-07
PL3200762T3 (pl) 2019-08-30
SG11201702666SA (en) 2017-04-27
DK3200762T3 (da) 2019-05-06
TR201906108T4 (tr) 2019-05-21
CN106999542B (zh) 2021-02-02
KR102494511B1 (ko) 2023-01-31
EP3520777B1 (en) 2020-09-30
WO2016050933A1 (en) 2016-04-07
HRP20190747T1 (hr) 2019-07-12
AU2015326847A1 (en) 2017-04-13
LT3200762T (lt) 2019-06-10
IL251480A0 (en) 2017-05-29
BR112017006816A2 (pt) 2018-01-09
PT3200762T (pt) 2019-05-28
RS58792B1 (sr) 2019-07-31
EP3200762A1 (en) 2017-08-09
ES2721401T3 (es) 2019-07-31
CY1121803T1 (el) 2020-07-31
CN106999542A (zh) 2017-08-01
PH12017500538A1 (en) 2017-08-07
CO2017004442A2 (es) 2017-09-29
EP3200762B1 (en) 2019-03-27
CA2962120A1 (en) 2016-04-07
JP6626890B2 (ja) 2019-12-25
EP3520777A1 (en) 2019-08-07
RU2017114144A (ru) 2018-11-06
JP2017530138A (ja) 2017-10-12
HUE044289T2 (hu) 2019-10-28
RU2702335C2 (ru) 2019-10-08
US11033602B2 (en) 2021-06-15
US20190022171A1 (en) 2019-01-24
RU2017114144A3 (es) 2019-04-17

Similar Documents

Publication Publication Date Title
MA40630A (fr) Dispositif d'administration d'un agent thérapeutique muni d'une canule et d'une aiguille pouvant avancer.
EP3204095B8 (en) Inhalation device for use in aerosol therapy of respiratory diseases
MX2021008564A (es) Formulaciones de sal de nicotina para dispositivos de aerosol y metodos de los mismos.
PH12016500433A1 (en) Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
PH12016501719A1 (en) Flavoured nicotine powder inhaler
HUE053891T2 (hu) Nazális porlasztófúvóka orvosi fecskendõben való használatra
MX2016014089A (es) Inhalador de polvo de nicotina.
TWD175896S (zh) 呼吸裝置
MY193694A (en) Membrane-adherent self-assembled systems for treatment of ocular disorders
TWD175890S (zh) 呼吸裝置
TWD175895S (zh) 呼吸裝置
PH12017500538A1 (en) Inhalation device
NZ734706A (en) Method and apparatus for treatment of respiratory disorders
PH12017500516A1 (en) Compositions
GB2534488A (en) Measured dose dispenser
CO2017001903A2 (es) Entrega coordinada del tratamiento del epoc
MX2016006377A (es) Un medicamento inhalable.
WO2016082807A3 (zh) 伊曲康唑的新用途
PH12015501179A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
TWD165496S (zh) 噴霧器
IL247557B (en) Nicotine powder inhaler
GB201510641D0 (en) Inhalation device for administering sustained release drug delivery to the lungs
TH1701001848A (th) อุปกรณ์สูดดม
GEP20207079B (en) Pharmaceutically acceptable salts of pirlindole enantiomers for use in medicine

Legal Events

Date Code Title Description
FG Grant or registration